20072024

Research activity per year

Network

Remy Petersen

Person: Academic

Julie Hagen

Person: Academic

Han Tan

Person: Academic

Arjen Sutterland

Person: Academic

Marc A. Riedl

  • University of Amsterdam

External person

Markus Magerl

  • Charité – Universitätsmedizin Berlin
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

External person

Marcus Maurer

  • Charité – Universitätsmedizin Berlin
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

External person

Jonathan A. Bernstein

  • University of Amsterdam

External person

Laura Bordone

  • University of Amsterdam
  • Ionis

External person

Timothy Craig

  • University of Amsterdam

External person

Lilian Agnes Varga

  • Semmelweis University

External person

Noémi-Anna Bara

  • Mediquest Clinical Research Centre

External person

Grzegorz Porebski

  • Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland

External person

Sandra A. Nieto-Martinez

  • Instituto Nacional de Pediatria

External person

Allen Phillip Kaplan

  • Medical University of South Carolina

External person

Elias Toubi

  • Technion-Israel Institute of Technology

External person

Peter J. Spaeth

  • University of Bern

External person

Eugene Schneider

  • University of Amsterdam

External person

Wei-Te Lei

  • Mackay Memorial Hospital Taiwan

External person

Farrukh Rafique Sheikh

  • Alfaisal University

External person

Hilary Longhurst

  • University College London
  • Cambridge University Hospitals NHS Foundation Trust

External person

William R. Lumry

  • University of Amsterdam

External person

Kenneth B. Newman

  • University of Amsterdam

External person

W. R. Lumry

  • University of Texas Southwestern Medical Center

External person

Brenda F. Baker

  • University of Amsterdam

External person

Jason Raasch

  • University of Amsterdam

External person

E. Aygören-Pürsün

  • Goethe University Frankfurt

External person

Alexey S. Revenko

  • University of Amsterdam

External person

Frederikus A. Klok

  • Leiden University

External person

Dinh Nguyen

  • VinUniversity

External person

Paul K. Audhya

  • KalVista Pharmaceuticals

External person

Sara Roshani

  • Rijksuniversiteit Leiden: Faculteit Geneeskunde

External person

Jonathan Peter

  • University of Cape Town

External person

A. Zanichelli

  • Ospedale Luigi Sacco

External person

Raffi Tachdjian

  • University of Amsterdam

External person

Michael E. Manning

  • University of Amsterdam

External person

Charvi Nanavati

  • University of Amsterdam

External person

Christopher M. Yea

  • KalVista Pharmaceuticals

External person

William R. Smith

  • Royal Adelaide Hospital

External person

I. M. Saguer

  • Haemophilia Centre Rhine Main (HZRM)

External person

Yuanxin Xu

  • The University of Auckland

External person

H. Henry Li

  • Institute for Asthma and Allergy

External person

Gwendolyn E. Kaeser

  • University of Amsterdam

External person

N. Prior

  • Hospital Severo Ochoa

External person

Roman Hakl

  • Masaryk University

External person

Menno V. Huisman

  • Leiden University

External person

Doris Wilflingseder

  • Innsbruck Medical University

External person

Thomas Buttgereit

  • Charité – Universitätsmedizin Berlin
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

External person

I. Boccon-Gibod

  • Université Grenoble Alpes

External person

Bo W. Han

  • The University of Auckland

External person

David Lebwohl

  • The University of Auckland

External person

Carri Boiselle

  • The University of Auckland

External person

Cindy Lui

  • Ionis Pharmaceuticals

External person

Matthew Iverson

  • KalVista Pharmaceuticals

External person

Laura Sepp-Lorenzino

  • The University of Auckland

External person

Nicholas J. Wareham

  • University of Cambridge

External person

A. Bygum

  • University of Southern Denmark

External person

David Maag

  • The University of Auckland

External person

R. G. Farquharson

  • Liverpool Women's NHS Foundation Trust

External person

Eliana D. Clark

  • The University of Auckland

External person

Samantha Soukamneuth

  • The University of Auckland

External person

R. Gower

  • Principle Research Solutions

External person

Padmalal Gurugama

  • The University of Auckland

External person

Veronica J. Alexander

  • University of Amsterdam

External person

James S. Butler

  • The University of Auckland

External person

Andreas Maetzel

  • KalVista Pharmaceuticals
  • Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Canada

External person

Viktoria Zaderer

  • Innsbruck Medical University

External person

W. Aberer

  • Medical University of Graz

External person

M. Stobiecki

  • Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland

External person

Mrinal Y. Shah

  • The University of Auckland

External person

A. Robert Macleod

  • University of Amsterdam

External person

Tessa Liefers

  • University of Amsterdam

External person

A. Malbran

  • Asma e Inmunología Clínica

External person

Vesna Grivcheva-Panovska

  • SS Cyril and Methodius University in Skopje

External person

Jessica Seitzer

  • The University of Auckland

External person

Bruce L. Zuraw

  • University of California at San Diego

External person

M. Cancian

  • Azienda Ospedaliera di Padova

External person

Karen Lindsay

  • The University of Auckland

External person

Tamar Kinaciyan

  • Medical University of Vienna

External person

Mark D. McKee

  • The University of Auckland

External person

Magdalena Dziadzio

  • University College London

External person

Adele Golden

  • The University of Auckland

External person

S. Kiani-Alikhan

  • Barts Health NHS Foundation Trust, London, UK

External person

Philip C. G. Klein

  • Erasmus Universiteit Rotterdam
  • Erasmus School of Health Policy & Management

External person

Yiwen Deng

  • Ionis Pharmaceuticals

External person

Simon Francis Thomsen

  • University of Copenhagen

External person

A. Banerji

  • Harvard University

External person

James Hao

  • KalVista Pharmaceuticals

External person

William B. Smith

  • Royal Adelaide Hospital

External person

Roy G. Farquharson

  • Liverpool Women's Hospital

External person

Ahmed M. Abdelhady

  • The University of Auckland

External person

Feroza Dawood

  • Liverpool Women's Hospital

External person

Drahomir Aujesky

  • University of Bern

External person

Joseph D. Vogel

  • The University of Auckland

External person

E. Marleen Kemper

  • University of Amsterdam

External person

Daniel K. Lee

  • KalVista Pharmaceuticals

External person

John Leonard

  • The University of Auckland

External person

Paul L. den Exter

  • Leiden University

External person